Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Neurology | Musculoskeletal | Family Medicine
Disease Category: Chronic Pain
Location: United States, OK

Clinical Trial Details

Overview

Research Study Summary

Do you suffer from chronic, moderate to severe pain?

Purpose

A Multi-center, Primary Care-Based, Open-Label Study to Assess the Success of Converting Opioid-Experienced Patients, with Chronic, Moderate to Severe Pain, to EMBEDA™ Using a Standardized Conversion Guide, and to Identify Behaviors Related to Prescription Opioid Abuse, Misuse, and Diversion

Patient Inclusion Criteria:

  • Patient is at least 21 years of age
  • Chronic (>3 month) moderate to severe pain who requires around the clock opioid use

Patient Exclusion Criteria:

  • Allergy / Intolerance to morphine or other opiates
  • Acute / Severe asthma or Chronic Obstructive Pulmonary Disease (COPD)
  • Patient reports migraine as the primary pain source
  • Patient has had more than 2 lower back pain surgeries

To Learn more
Phase

4

Gender

Both Male and Female

Age

21 and up

Overall Status

Recruiting

Facility Type

N/A

Contact

Health Research Institute
1044 S. W. 44th Street Suite 518
Oklahoma City, OK 73109
Phone: 405.616.4888
Fax: 405.616.4885

View Map

Research Center Information: Health Research Institute

If you would like to learn more about participating in this research study, please email the trial contact using the form below.

Name:
Address:
City:
State:
Zip/Postal Code:
Country:
Phone:
Email:  
Message:
 
Please leave this field empty.

CW ID: 169129

Date Last Changed: July 23, 2013


DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.